NKG2D receptor (NKG2D)

The **NKG2D receptor** is an activating transmembrane receptor primarily found on natural killer (NK) cells, CD8^+ T cells, and some γδ T cells[3][4][7]. It is part of the C-type lectin-like receptor family and is encoded by the *KLRK1* gene. **NKG2D recognizes and binds to a family of stress-induced ligands** (including MICA, MICB, and ULBP1–6 in humans), which are typically upregulated in cells that are stressed, infected, or transformed (such as tumor cells)[3][7]. Upon ligand binding, NKG2D triggers cytotoxic responses in NK cells and provides co-stimulatory signals in T cells, contributing to immune surveillance against cancer and infections[3][4][7]. The molecular interaction is highly regulated: NKG2D requires association with the adapter protein DAP10 (in humans) for surface expression and signal transduction, leading to the activation of signaling pathways such as PI3K and Grb2-Vav1. In mice and certain human contexts, DAP12 may also participate, introducing further activation potential[3][7]. The NKG2D/ligand axis is involved in a variety of disease processes. High expression of ligands on tumors can activate immune responses, but tumors may also evade immunity by shedding soluble NKG2D ligands, leading to downregulation or desensitization of the receptor and impaired immune cell function[2][7]. The concept "NKG2D ligand interaction" is not itself a molecule or receptor but refers to the dynamic molecular interaction between the NKG2D receptor and its multiple ligands. The proper therapeutic target is the **NKG2D receptor**, or specifically its interaction with defined ligand proteins (such as MICA, MICB, or specific ULBPs). For structured annotations, each ligand should be specified separately. **Note:** - There is something wrong with the entry "NKG2D ligand interaction": it is not a canonical molecule or protein, but a molecular interaction/process. The accurate target is the **NKG2D receptor** (or each individual ligand), so **is_incorrect** should be marked as true based on the conventions stated.

Other names

Natural killer group 2 member D receptorKiller cell lectin-like receptor subfamily K, member 1 (KLRK1)NK cell-activating receptor

Immune modulation (enhancing NK and cytotoxic T cell activity through blocking or engaging NKG2D or its ligands), Tumor immune evasion (by modulating ligand shedding or receptor downregulation)[2][7]